Page last updated: 2024-08-16

ribavirin and Cardiomyopathy, Congestive

ribavirin has been researched along with Cardiomyopathy, Congestive in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abravanel, F; Akhavan, S; Calmus, Y; Conti, F; Guillemain, R; Lecuyer, L; Marcelin, AG; Mazzola, A; Peytavin, G; Poynard, T; Roque-Afonso, AM; Todesco, E	1
Asselah, T; Blazquez, M; Bonnet, J; Cohen, A; Condat, B; Estampes, B; Marcellin, P; Ngo, Y; O'Toole, D; Zanditenas, D	1
Abelmann, WH; Crumpacker, CS; Kawai, C; Matsumori, A	1

Reviews

1 review(s) available for ribavirin and Cardiomyopathy, Congestive

Article	Year
Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:3 Topics: Antiviral Agents; Cardiomyopathy, Dilated; Drug Administration Schedule; Drug Therapy, Combination; Fatal Outcome; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2006

Article

Year

Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C.

European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:3

Topics: Antiviral Agents; Cardiomyopathy, Dilated; Drug Administration Schedule; Drug Therapy, Combination; Fatal Outcome; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2006

Other Studies

2 other study(ies) available for ribavirin and Cardiomyopathy, Congestive

Article	Year
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective. Antiviral therapy, 2018, Volume: 23, Issue:5 Topics: Antiviral Agents; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure	2018
Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus. Japanese circulation journal, 1987, Volume: 51, Issue:6 Topics: Animals; Autoantibodies; Cardiomyopathy, Dilated; Disease Models, Animal; Encephalomyocarditis virus; Endomyocardial Fibrosis; Enterovirus Infections; Immunity, Maternally-Acquired; Interferon Type I; Isoenzymes; Mice; Mice, Inbred DBA; Myocarditis; Myocardium; Myosins; Recombinant Proteins; Ribavirin; Viral Vaccines	1987

Article

Year

Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.

Antiviral therapy, 2018, Volume: 23, Issue:5

Topics: Antiviral Agents; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure

2018

Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.

Japanese circulation journal, 1987, Volume: 51, Issue:6

Topics: Animals; Autoantibodies; Cardiomyopathy, Dilated; Disease Models, Animal; Encephalomyocarditis virus; Endomyocardial Fibrosis; Enterovirus Infections; Immunity, Maternally-Acquired; Interferon Type I; Isoenzymes; Mice; Mice, Inbred DBA; Myocarditis; Myocardium; Myosins; Recombinant Proteins; Ribavirin; Viral Vaccines

1987